Latest News Feed
Uploaded
08-29-2026
Prof Giuseppe Rosano on Key Updates to the Heart Failure Guidelines
Prof Giuseppe Rosano on Key Updates to the Heart Failure Guidelines New heart failure guidelines place greater emphasis o ...
Uploaded
08-29-2026
PRESC1SE MI ESC 0 1 Hour Algorithm in NSTEMI
PRESC1SE MI ESC 0 1 Hour Algorithm in NSTEMI Visit Radcliffe Cardiology: https://www.radcliffecardiology.com/ This conte ...
Uploaded
08-29-2026
CKD Guidelines What Will Change in Clinical Practice
CKD Guidelines What Will Change in Clinical Practice Visit Radcliffe Cardiology: https://www.radcliffecardiology.com/ Th ...
Uploaded
08-29-2026
CARDIO TTRansform Evaluates Eplontersen in ATTR-CM
CARDIO TTRansform Evaluates Eplontersen in ATTR-CM Visit Radcliffe Cardiology: https://www.radcliffecardiology.com/ This ...
Uploaded
08-29-2026
ACACIA HCM Evaluates Aficamten in Symptomatic Nonobstructive HCM
ACACIA HCM Evaluates Aficamten in Symptomatic Nonobstructive HCM Visit Radcliffe Cardiology: https://www.radcliffecardiol ...
Tweeted
08-29-2026
Radcliffe Cardiology
@radcliffeCARDIO 🩸 Is extended dual antiplatelet therapy always necessary after high-risk PCI? At #ESCCongress2026, Prof Byeoung-Keuk Kim discusses the A-CLOSE trial, which compared clopidogrel monotherapy with prolonged DAPT in 3,200 event-free patients following PCI with drug-eluting stentx6Q
Radcliffe Cardiology
@radcliffeCARDIO 🩸 Is extended dual antiplatelet therapy always necessary after high-risk PCI? At #ESCCongress2026, Prof Byeoung-Keuk Kim discusses the A-CLOSE trial, which compared clopidogrel monotherapy with prolonged DAPT in 3,200 event-free patients following PCI with drug-eluting stentx6Q
Tweeted
08-29-2026
Radcliffe Cardiology
@radcliffeCARDIO 🚨 ESC 2026 | New ESC CKD Guidelines What could the first ESC guidelines for cardiovascular disease and CKD mean for clinical practice? Dr Kevin Damman discusses screening, risk assessment and evidence-based cardiorenal therapies. 🔗 https://t.co/8ykxPu2PaW #ESC202ow.ly/vMjT50ZGS2rPu2PaW #ESC2026aLWWZ2
Radcliffe Cardiology
@radcliffeCARDIO 🚨 ESC 2026 | New ESC CKD Guidelines What could the first ESC guidelines for cardiovascular disease and CKD mean for clinical practice? Dr Kevin Damman discusses screening, risk assessment and evidence-based cardiorenal therapies. 🔗 https://t.co/8ykxPu2PaW #ESC202ow.ly/vMjT50ZGS2rPu2PaW #ESC2026aLWWZ2
Tweeted
08-29-2026
Radcliffe Cardiology
@radcliffeCARDIO 🎙️ Dr Van Spall & Dr Jasper Boeddinghaus discuss PRESC1SE-MI from #ESCCongress2026 Implementation of the ESC 0/1-hour pathway achieved: 📊 67,624 patient presentations 📊 Earlier repeat hs-cTn testing (190 min → 86 min) ✅ Non-inferior for death or new type 1 MI ://t.co/7vv87ugChS
Radcliffe Cardiology
@radcliffeCARDIO 🎙️ Dr Van Spall & Dr Jasper Boeddinghaus discuss PRESC1SE-MI from #ESCCongress2026 Implementation of the ESC 0/1-hour pathway achieved: 📊 67,624 patient presentations 📊 Earlier repeat hs-cTn testing (190 min → 86 min) ✅ Non-inferior for death or new type 1 MI ://t.co/7vv87ugChS
Tweeted
08-29-2026
Radcliffe Cardiology
@radcliffeCARDIO 🚨 HOT LINE TAKEAWAY | CARDIO-TTRansform A neutral trial, but not the end of the story. Dr Margot Davis explains the full ESC 2026 CARDIO-TTRansform results and what they reveal about: ✅ Eplontersen as monotherapy ✅ The role of background tafamidis therapy ✅3zjYoBtX6
Radcliffe Cardiology
@radcliffeCARDIO 🚨 HOT LINE TAKEAWAY | CARDIO-TTRansform A neutral trial, but not the end of the story. Dr Margot Davis explains the full ESC 2026 CARDIO-TTRansform results and what they reveal about: ✅ Eplontersen as monotherapy ✅ The role of background tafamidis therapy ✅3zjYoBtX6
Uploaded
08-29-2026
ACS After PCI: Is Prasugrel the Better Choice?
ACS After PCI: Is Prasugrel the Better Choice? Visit Radcliffe Cardiology: https://www.radcliffecardiology.com/ This cont ...
Tweeted
08-29-2026
Radcliffe Cardiology
@radcliffeCARDIO 🚨 ESC 2026 | SWITCH SWEDEHEART: Prasugrel vs Tcagrelor Could P2Y12 inhibitor selection in acute coronary syndrome be changing? Prof Elmir Omerovic discusses SWITCH SWEDEHEART, which enrolled 17,095 patients and compared prasugrel and ticagrelor. 🔗 Watch the full inter9Q0yZ7
Radcliffe Cardiology
@radcliffeCARDIO 🚨 ESC 2026 | SWITCH SWEDEHEART: Prasugrel vs Tcagrelor Could P2Y12 inhibitor selection in acute coronary syndrome be changing? Prof Elmir Omerovic discusses SWITCH SWEDEHEART, which enrolled 17,095 patients and compared prasugrel and ticagrelor. 🔗 Watch the full inter9Q0yZ7
Uploaded
08-29-2026
STAREE Investigates Statins for Healthy Adults Aged ≥70 Years
STAREE Investigates Statins for Healthy Adults Aged ≥70 Years Visit Radcliffe Cardiology: https://www.radcliffecardiology ...
Tweeted
08-29-2026
Radcliffe Cardiology
@radcliffeCARDIO 🚨 ESC 2026 | STAREE Investigates Statins for Healthy Adults Aged ≥70 Years Can statins improve outcomes in healthy adults aged ≥70 Years? Prof Sophia Zoungas discusses STAREE, which enrolled 9,971 participants and evaluated atorvastatin 40 mg versus placebo. 🔗 UEDx46mzGw
Radcliffe Cardiology
@radcliffeCARDIO 🚨 ESC 2026 | STAREE Investigates Statins for Healthy Adults Aged ≥70 Years Can statins improve outcomes in healthy adults aged ≥70 Years? Prof Sophia Zoungas discusses STAREE, which enrolled 9,971 participants and evaluated atorvastatin 40 mg versus placebo. 🔗 UEDx46mzGw
Uploaded
08-29-2026
ESC 2026: CARDIO-TTRansform Evaluates Eplontersen in ATTR-CM
ESC 2026: CARDIO-TTRansform Evaluates Eplontersen in ATTR-CM At ESC Congress 2026, Dr Margot Davis (University of British ...
Uploaded
08-29-2026
New MI Definition Released: What Changed?
New MI Definition Released: What Changed? Visit Radcliffe Cardiology: https://www.radcliffecardiology.com/ This content i ...
Uploaded
08-29-2026
ACACIA HCM Evaluates Aficamten in Symptomatic Nonobstructive HCM
ACACIA HCM Evaluates Aficamten in Symptomatic Nonobstructive HCM Visit Radcliffe Cardiology: https://www.radcliffecardiol ...
Tweeted
08-29-2026
Radcliffe Cardiology
@radcliffeCARDIO 🚨 ESC 2026 | Fifth Universal Definition of Myocardial Infarction (UDMI) What has changed in the diagnosis and classification of myocardial infarction? Prof Kristin Newby discusses the updated definition, including the move to primary, secondary and procedure-related myocardigW1
Radcliffe Cardiology
@radcliffeCARDIO 🚨 ESC 2026 | Fifth Universal Definition of Myocardial Infarction (UDMI) What has changed in the diagnosis and classification of myocardial infarction? Prof Kristin Newby discusses the updated definition, including the move to primary, secondary and procedure-related myocardigW1
Tweeted
08-29-2026
Radcliffe Cardiology
@radcliffeCARDIO 📚 New #AERJournal Article: "Quantifying ECG Normality" 📚 Just Published! 🔓Access it here 👉 https://t.co/iV1dRQMW45 #CVImaging #MedEd #Electrophysiologyow.ly/KWVg106CTgYo/iV1dRQMW45 #CVImaging #MedEd #Electrophysiology o/Mo6W2PD4sK
Radcliffe Cardiology
@radcliffeCARDIO 📚 New #AERJournal Article: "Quantifying ECG Normality" 📚 Just Published! 🔓Access it here 👉 https://t.co/iV1dRQMW45 #CVImaging #MedEd #Electrophysiologyow.ly/KWVg106CTgYo/iV1dRQMW45 #CVImaging #MedEd #Electrophysiology o/Mo6W2PD4sK
Tweeted
08-28-2026
Radcliffe Cardiology
@radcliffeCARDIO ACACIA-HCM at #ESCCongress2026 | Interview with @MasriAhmadMD 517 patients with symptomatic non-obstructive HCM. 📈 KCCQ-CSS: +11.4 vs +8.4 (p=0.02) 📈 Peak VO₂: +0.64 vs -0.03 mL/kg/min (p=0.003) "We take care of these patients with non-obstructive HCM, and we don'tBLfgKdCc
Radcliffe Cardiology
@radcliffeCARDIO ACACIA-HCM at #ESCCongress2026 | Interview with @MasriAhmadMD 517 patients with symptomatic non-obstructive HCM. 📈 KCCQ-CSS: +11.4 vs +8.4 (p=0.02) 📈 Peak VO₂: +0.64 vs -0.03 mL/kg/min (p=0.003) "We take care of these patients with non-obstructive HCM, and we don'tBLfgKdCc
